Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_assertion type Assertion NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_head.
- NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_assertion description "[Prostate cancer was used as a paradigm because this tumor type is reliant at all stages of the disease on androgen receptor (AR) signaling, and cyclin D1 has been shown to negatively modulate AR-dependent expression of prostate-specific antigen (KLK3/PSA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_provenance.
- NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_assertion evidence source_evidence_literature NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_provenance.
- NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_assertion SIO_000772 21212260 NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_provenance.
- NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_assertion wasDerivedFrom befree-2016 NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_provenance.
- NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_assertion wasGeneratedBy ECO_0000203 NP863596.RAJnb_LMGomBB4SxBU4I71uJzpV_Z9l5IAxm3HDxsePMk130_provenance.